The Supreme Economic Court of Ukraine has refused to consider Gazprom’s appeal on the $3.4 billion fine imposed against the Russian energy firm by Kiev authorities.
In January, Ukraine fined Gazprom for what it called the abuse of its dominant position on the country’s gas transit market.
The Ukrainian anti-monopoly committee insists Gazprom has reduced the volume of gas it transits through the country, undermining the transit contract with Russia. According to the terms of the agreement, Gazprom was obliged to pump about 100 billion cubic meters of gas in 2014 through Ukraine. Instead, the Russian company pumped only 62 billion cubic meters of gas. Kiev’s Naftogaz has estimated the lost revenue at $6 billion.
Gazprom says it does no business in the country, as it gives the gas to Ukraine at Russia’s western border.
The Russian company called the actions of Ukraine “an attempt to exert pressure” and tried to challenge the penalty, but the lower courts for various reasons rejected the counter claims.
Russia and Ukraine have numerous counter claims over gas-related issues. Gazprom claims Ukraine’s Naftogaz owes the Russian company $31.759 billion over failure to purchase the contracted amount of gas.
Full Content: RT
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas